Seer

formerly Seer BioIPO

The promise of proteomics NOW IN FULL VIEW

Public · Redwood City, United States · Founded 2017 · $197.5M raised

Employees
51–200
Founded
2017
Business Model
B2B
Website
seer.bio
Total Funding
$197.5M
Last Round
$55.0M Series DJul 2020
Rounds
8
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 9 funding rounds and 10 investors for this company. The full record is or through the API.

About

Seer enables unbiased, deep, rapid proteomics at scale through the Proteograph Product Suite. The platform captures more protein groups and enhances peptide-level coverage, giving researchers higher-resolution views of biological complexity across human and nonhuman samples. Teams can bring the Proteograph Product Suite in-house, run a project with the Seer Technology Access Center, or work through a Seer service provider or Center of Excellence. Seer reports more than 36,000 proteins and over 300,000 peptides providing high-resolution information on the proteome.

Summary

Seer is a Biotech company based in Redwood City, United States, founded in 2017. It has raised $197.5M in total across 8 rounds, most recently a $55.0M Series D round in Jul 2020. Investors include Invus, Maverick Ventures and J.P. Morgan.

Tech & App Stack

11 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPODec 2020
$175.0M

Sign up to see all 9 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Seer on Indexed.vc
<a href="https://indexed.vc/companies/seer"><img src="https://indexed.vc/api/badge/company/seer" alt="Seer on Indexed.vc" width="260" height="76" /></a>